CLLS
Price
$4.27
Change
-$0.00 (-0.00%)
Updated
Jan 15, 11:07 AM (EDT)
Capitalization
421.65M
55 days until earnings call
Intraday BUY SELL Signals
SLN
Price
$5.75
Change
-$0.12 (-2.04%)
Updated
Jan 15, 12:04 PM (EDT)
Capitalization
170.04M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLLS vs SLN

Header iconCLLS vs SLN Comparison
Open Charts CLLS vs SLNBanner chart's image
Cellectis SA
Price$4.27
Change-$0.00 (-0.00%)
Volume$104
Capitalization421.65M
Silence Therapeutics
Price$5.75
Change-$0.12 (-2.04%)
Volume$700
Capitalization170.04M
CLLS vs SLN Comparison Chart in %
CLLS
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLLS vs. SLN commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Hold and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CLLS: $4.27 vs. SLN: $5.87)
Brand notoriety: CLLS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 59% vs. SLN: 123%
Market capitalization -- CLLS: $421.65M vs. SLN: $170.04M
CLLS [@Biotechnology] is valued at $421.65M. SLN’s [@Biotechnology] market capitalization is $170.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • CLLS’s TA Score: 4 bullish, 4 bearish.
  • SLN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CLLS is a better buy in the short-term than SLN.

Price Growth

CLLS (@Biotechnology) experienced а -6.15% price change this week, while SLN (@Biotechnology) price change was +1.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CLLS is expected to report earnings on Mar 11, 2026.

SLN is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($422M) has a higher market cap than SLN($170M). SLN YTD gains are higher at: -3.454 vs. CLLS (-11.777). CLLS has higher annual earnings (EBITDA): -6.07M vs. SLN (-81.06M). CLLS has more cash in the bank: 190M vs. SLN (102M). SLN has less debt than CLLS: SLN (182K) vs CLLS (92.8M). CLLS has higher revenues than SLN: CLLS (75.3M) vs SLN (25.8M).
CLLSSLNCLLS / SLN
Capitalization422M170M248%
EBITDA-6.07M-81.06M7%
Gain YTD-11.777-3.454341%
P/E RatioN/AN/A-
Revenue75.3M25.8M292%
Total Cash190M102M186%
Total Debt92.8M182K50,989%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSSLN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 23 days ago
78%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGLX82.920.95
+1.16%
Janus Henderson Global Life Sciences D
WRCGX6.800.04
+0.59%
William Blair China Growth R6
GIDAX8.940.04
+0.45%
Goldman Sachs Intl Eq Div & Prem A
SSCOX6.27N/A
N/A
Touchstone Small Company C
VLIIX14.47-0.09
-0.62%
Value Line Capital Appreciation Instl

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+0.47%
CMVLF - CLLS
82%
Closely correlated
N/A
SLN - CLLS
43%
Loosely correlated
-0.68%
MDGL - CLLS
40%
Loosely correlated
+2.29%
PMVP - CLLS
38%
Loosely correlated
-1.72%
AXON - CLLS
36%
Loosely correlated
-1.92%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-0.68%
CLLS - SLN
43%
Loosely correlated
+0.47%
CMVLF - SLN
38%
Loosely correlated
N/A
TSHA - SLN
38%
Loosely correlated
+2.86%
PCVX - SLN
36%
Loosely correlated
+5.41%
IMTX - SLN
36%
Loosely correlated
+4.80%
More